BMRN

BioMarin Pharmaceutical Inc. – Consensus ‘buy’ rating and 22.5% Upside Potential

BioMarin Pharmaceutical Inc. with ticker code (BMRN) have now 24 analysts in total covering the stock. The consensus rating is pointing to ‘buy’. The target price High/Low ranges between $170.00..

BioMarin Pharmaceutical Inc. – Consensus ‘buy’ rating and 24.3% Upside Potential

BioMarin Pharmaceutical Inc. with ticker code (BMRN) now have 24 confirmed analysts covering the stock with the consensus suggesting a rating of ‘buy’. The range between the high target price..

BioMarin Pharmaceutical Inc. – Consensus ‘buy’ rating and 25.9% Upside Potential

BioMarin Pharmaceutical Inc. with ticker code (BMRN) now have 24 confirmed analysts covering the stock with the consensus suggesting a rating of ‘buy’. The range between the high target price..

BioMarin Pharmaceutical Inc. – Consensus ‘buy’ rating and 30.3% Upside Potential

BioMarin Pharmaceutical Inc. with ticker code (BMRN) have now 23 confirmed analysts covering the stock with the consensus suggesting a rating of ‘buy’. The range between the high target price..

BioMarin Pharmaceutical Inc. – Consensus ‘buy’ rating and 36.8% Upside Potential

BioMarin Pharmaceutical Inc. with ticker code (BMRN) have now 22 confirmed analysts covering the stock with the consensus suggesting a rating of ‘buy’. The target price High/Low ranges between $185.00..

BioMarin Pharmaceutical Inc. – Consensus ‘buy’ rating and 44.4% Upside Potential

BioMarin Pharmaceutical Inc. which can be found using ticker (BMRN) now have 22 confirmed analysts covering the stock with the consensus suggesting a rating of ‘buy’. The range between the..

BioMarin Pharmaceutical Inc. – Consensus ‘buy’ rating and 32.7% Upside Potential

BioMarin Pharmaceutical Inc. which can be found using ticker (BMRN) now have 22 market analysts covering the stock. The analyst consensus now points to a rating of ‘buy’. The range..

BioMarin Pharmaceutical Inc. – Consensus ‘buy’ rating and 32.3% Upside Potential

BioMarin Pharmaceutical Inc. which can be found using ticker (BMRN) now have 22 analysts in total covering the stock. The consensus rating is pointing to ‘buy’. The target price High/Low..

BioMarin Pharmaceutical Inc. – Consensus ‘buy’ rating and 28.5% Upside Potential

BioMarin Pharmaceutical Inc. which can be found using ticker (BMRN) have now 23 market analysts covering the stock. The analyst consensus now points to a rating of ‘buy’. The target..

BioMarin Pharmaceutical Inc. – Consensus ‘buy’ rating and 24.4% Upside Potential

BioMarin Pharmaceutical Inc. with ticker code (BMRN) now have 23 analysts in total covering the stock. The consensus rating is pointing to ‘buy’. The range between the high target price..

Search

Funds

BMRN

Search

Funds

BMRN

FTSE 100

Funds